key: cord-0798745-6b45yx1a
authors: Roca, Elena; Ventura, Laura; Zattra, Costanza M; Lombardi, Carlo
title: EOSINOPENIA: An early, effective, and relevant COVID-19 biomarker?
date: 2020-09-02
journal: QJM
DOI: 10.1093/qjmed/hcaa259
sha: e2173ace75eaf6076279fb10570b99f3152d87ce
doc_id: 798745
cord_uid: 6b45yx1a

nan

. The Authors argue that there is an association between eosinophil count and Covid-19, but that eosinopenia appears not to be associated with the unfavourable progression of the disease.

Actually there are not a lot of studies about this topic and those that exist relate to Chinese case series.

We report our case history relating to patients admitted to our Covid-19 Unit in our hospital in Brescia, one of the Northern Italian cities most affected by the SARS-Cov-2.

Eosinophils originate from CD34+stem cells in the bone marrow as terminally differentiated cells; in fact they no longer proliferate once formed (2, 3) . Under physiological conditions, the eosinophil count only covers a small percentage of circulating leukocytes, about 1-3%, but their levels may vary in different conditions (4).

In the MERS-CoV, like in Covid-19, was demonstrated that patients had extensive inflammatory cellular infiltrates in the interstitium and alveoli (5) and, furthermore, they contribute to lung damage as they compromise lung function too (2) . Consequently, some authors speculated that probably neutrophils, eosinophilis, macrophages and lymphocytes migrate from peripheral blood into the lung tissue, causing neutropenia, eosinopenia lymphopenia (6) .

Also in italian patients admitted to our Unit it was shown a significant decrease in circulating eosinophils. In the 294 patients (M/F = 88/206; age range: 24-95 yrs; mean age: 68.8 yrs) admitted to our Unit, the median value of eosinophil count was 0.01 10^9/L (mean 0.028, SD ± 0.04).

Moreover, it was shown that in 246 patients (83.7%) there was a decrease in circulating eosinophils (eosinophils < 0.05 10^9/L). Eosinophil count was correlated with active smoking (p-value=0.04), chronic obstructive pulmonary disease (COPD) (p-value=0.037), haemoglobin levels (p-value=0.016), White Blood Cells (p-value<0.01) and platelets (p-value<0.01) counts.

The Welch two sample t-test showed that the mean value of eosinophil was significantly smaller in deceased patients (p-value = 0.032); the ANOVA analysis indicated also that eosinopenia had a weak association with the unfavorable progression of the disease (p-value = 0.049) (table 1).

Some Authors have also speculated that the improvement of eosinopenia may be an indicator of COVID-19 improvement too, but more data will be needed to confirm this (7, 8) .

In conclusion we think that the data obtained from our study confirm that the evaluation of the eosinophilic blood count represents a valid biomarker: the presence of eosinopenia can aid in early diagnosis of COVID-19 and it may be a useful tool in deciding whether to promptly isolate a patient and initiate specific therapies while waiting for confirmatory test results. Furthermore, persistent eosinopenia after admission correlated with prognostic evolution (high disease severity and low rates of recovery). Finally, Influenza pneumonia and COVID-19 are two different types of respiratory viral pneumonia with very similar clinical manifestations, but eosinopenia may not be typically observed in patients with influenza pneumonia. 

Eosinophil count in severe coronavirus disease 2019 QJM

Eosinophils as diagnostic tools in chronic lung disease

Eosinophil development, disease involvement and therapeutic suppression

Eosinophilia and diseases: clinical revision of 1862 cases

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?

Kenv Pan, et al. Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

Eosinophil responses during COVID-19 infections and coronavirus vaccination